The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: Results from the international metastatic renal cell cancer database consortium

European Urology

Volumn 65, Issue 4, 2014, Pages 723-730

  Schutz, Fabio A B ^a   Xie, Wanling ^a   Donskov, Frede ^b   Sircar, Monica ^c   McDermott, David F ^a   Rini, Brian I ^d   Agarwal, Neeraj ^e   Pal, Sumanta Kumar ^f   Srinivas, Sandy ^g   Kollmannsberger, Christian ^h   North, Scott A ⁱ   Wood, Lori A ^j   Vaishampayan, Ulka ^k   Tan, Min Han ^l   MacKenzie, Mary J ^m   Lee, Jae Lyun ⁿ   Rha, Sun Young ^o   Yuasa, Takeshi ^p   Heng, Daniel Y C ^q   Choueiri, Toni K ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d TAUSSIG CANCER INSTITUTE   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁱ CROSS CANCER INSTITUTE   (Canada)

^j DALHOUSIE UNIVERSITY   (Canada)

^k WAYNE STATE UNIVERSITY   (United States)

^l DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^m LONDON REGIONAL CANCER PROGRAM   (Canada)

ⁿ University of Ulsan College of Medicine   (South Korea)

^o Yonsei University College of Medicine   (South Korea)

^p CANCER INSTITUTE HOSPITAL   (Japan)

^q TOM BAKER CANCER CENTRE   (Canada)

more..

Author keywords

Anti VEGF; Hyponatremia; Prognostic factors; Renal cell cancer

Indexed keywords

ANTI-VEGF; HYPONATREMIA; PROGNOSTIC FACTORS; RENAL CELL CANCER;

CARCINOMA, RENAL CELL; DATABASES, FACTUAL; FEMALE; HUMANS; HYPONATREMIA; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; PROGNOSIS; RETROSPECTIVE STUDIES; SODIUM; TOR SERINE-THREONINE KINASES; TREATMENT OUTCOME;

EID: 84894412753     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.10.013     Document Type: Article

References (26)

1. American Cancer Society. Cancer facts and figures 2012. American Cancer Society Web site. http://www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-031941.pdf.
2. D.Y. Heng, W. Xie, and M.M. Regan et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 2009 5794 5799
3. R.J. Motzer, M. Mazumdar, and J. Bacik et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma J Clin Oncol 17 1999 2530 2540
4. G.P. Patel, and R.A. Balk Recognition and treatment of hyponatremia in acutely ill hospitalized patients Clin Ther 29 2007 211 229
5. T. Berghmans, M. Paesmans, and J.J. Body A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis Supportive Care Cancer 8 2000 192 197
6. A. Luca, B. Angermayr, and G. Bertolini et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis Liver Transpl 13 2007 1174 1180
7. V. Nair, M.S. Niederman, N. Masani, and S. Fishbane Hyponatremia in community-acquired pneumonia Am J Nephrol 27 2007 184 190
8. J. Rossi, M. Bayram, and J.E. Udelson et al. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial Acute Card Care 9 2007 82 86
9. A.N. Jeppesen, H.K. Jensen, and F. Donskov et al. Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma Br J Cancer 102 2010 867 872
10. T.I. Huo, H.C. Lin, and C.Y. Hsia et al. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey Dig Liver Dis 40 2008 882 889
11. H.S. Kim, S.Y. Yi, and H.J. Jun et al. Clinical outcome of gastric cancer patients with bone marrow metastases Oncology 73 2007 192 197
12. L. Gandhi, and B.E. Johnson Paraneoplastic syndromes associated with small cell lung cancer J Natl Compr Canc Netw 4 2006 631 638
13. N.S. Vasudev, J.E. Brown, and S.R. Brown et al. Prognostic factors in renal cell carcinoma: association of preoperative sodium concentration with survival Clin Canc Res 14 2008 1775 1781
14. A. Kawashima, A. Tsujimura, and H. Takayama et al. Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy Int J Urol 19 2012 1050 1057 author reply 1058-9
15. V. Arroyo, M. Bernardi, and M. Epstein et al. Pathophysiology of ascites and functional renal failure in cirrhosis J Hepatol 6 1988 239 257
16. A. Gines, A. Escorsell, and P. Gines et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites Gastroenterology 105 1993 229 236
17. M. Gheorghiade, J.S. Rossi, and W. Cotts et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial Arch Intern Med 167 2007 1998 2005
18. Y.N. Chao, N.C. Chiu, and F.Y. Huang Clinical features and prognostic factors in childhood pneumococcal meningitis J Microbiol Immunol Infect 41 2008 48 53
19. A. Yaghoubian, C. de Virgilio, and C. Dauphine et al. Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft-tissue infections Arch Surg 142 2007 840 846 discussion 844-6
20. J.B. Sorensen, M.K. Andersen, and H.H. Hansen Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease J Intern Med 238 1995 97 110
21. Y.P. Talmi, H.T. Hoffman, and B.F. McCabe Syndrome of inappropriate secretion of arginine vasopressin in patients with cancer of the head and neck Ann Otol Rhinol Laryngol 101 1992 946 949
22. J.K. Maesaka, S. Gupta, and S. Fishbane Cerebral salt-wasting syndrome: does it exist? Nephron 82 1999 100 109
23. N. Aggerholm-Pedersen, P. Rasmussen, and H. Dybdahl et al. Serum natrium determines outcome of treatment of advanced GIST with imatinib: a retrospective study of 80 patients from a single institution ISRN Oncol 2011 2011 523915
24. T. Berghmans Hyponatremia related to medical anticancer treatment Support Care Cancer 4 1996 341 350
25. R. Macfarlane, D.Y. Heng, and W. Xie et al. The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy Cancer 118 2012 365 370
26. F. Gankam-Kengne, C. Ayers, and A. Khera et al. Mild hyponatremia is associated with an increased risk of death in an ambulatory setting Kidney Int 83 2013 700 706